TheraSkin® Real Human Skin for Treatment of Chronic Wounds Now available through Premier Contract

Montag, 19.06.2017 21:20 von

PR Newswire

NEWPORT NEWS, Va., June 19, 2017 /PRNewswire/ -- Soluble Systems LLC is pleased to announce that Premier Inc, a healthcare improvement company (NASDAQ: PINC) has signed a national contract effective June 15, 2017 which makes TheraSkin® available to aid in the treatment of patients within Premier's 3,750 hospitals as well as 130,000 other provider organizations of care nationwide.

A key factor in selecting the appropriate treatment for advanced wound therapy is the total value it provides the patient – specifically, faster healing with as few applications as possible. TheraSkin provides all the relevant characteristics to heal a wound, because it is real skin.  Backed by evidence supporting reduced time to heal with few applications, TheraSkin is an excellent option for patients and clinicians who are interested in a safe, effective and timely healing for their wounds. 

"TheraSkin provides a powerful treatment option at an attractive price point for our customers.  With the signing of this agreement, we are thrilled to provide our clinical and economic solution to Premier's vast partnership of healthcare providers. We are confident that TheraSkin will be a trusted choice for clinicians and patients looking to heal their wounds in a timely fashion and at a reasonable cost," states Allan Staley, CEO, Soluble Systems, LLC.

TheraSkin is one of the fastest growing products in the advanced wound care market. A retrospective clinical study of 188 consecutive patients published in Foot & Ankle Specialist demonstrated healing rates of 60% at 12 weeks for both Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU) evaluated in the study. (1)

1)

Landsman A.et al, Retrospective Study of 188 Consecutive Patients with a Biologically Active Human Skin Allograft (TheraSkin) for Diabetic Foot and Venous Leg Ulcers, Foot & Ankle Specialist, Feb. 2011. Volume 4, no 1:29-41

About TheraSkin: TheraSkin is a biologically active, cryopreserved human skin allograft for chronic wounds.  It can be used head-to-toe and has a fully developed extracellular matrix (ECM) with living cells and an "at ready" supply of human growth factors, cytokines and collagen to jumpstart the wound healing process. 

About Soluble Systems, LLC: Soluble Systems, LLC, markets an advanced wound care product under the brand name TheraSkin, designed to help healthcare professionals treat difficult-to-heal chronic wounds.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/theraskin-real-human-skin-for-treatment-of-chronic-wounds-now-available-through-premier-contract-300475949.html

SOURCE Soluble Systems LLC

Weitere Themen